Contact us Change country Investors Share information Stock options & treasury shares LANGUAGES EN | FR | NL  Stock options & treasury shares Stock options plans Managing cover of the stock option plan In December 1999, the company introduced an annual stock option program for Group executives worldwide. This program is covered by own shares purchased by the Solvay group. On 1 July 2013, through its subsidiary Solvay Stock Option Management SPRL, Solvay entrusted discretionary management of stock option plan cover to an independent banking institution. Voting and dividend rights attached to these shares are suspended as long as they are held by the company. Stock Options 2015 At December 31, 2015, Solvay Stock Option Management SPRL’s holdings of Solvay SA shares represented 1.989% (2,105,905 shares) of the Company capital. In 2015, stock options representing a total of 563,540 shares were exercised (it should be noted that options are in principle exercisable over a period of fi ve years after being frozen for three years). The stock options exercised break down as follows: 2005 stock option plan: 16,940 shares; 2006 stock option plan: 18,200 shares; 2007 stock option plan: 96,250 shares; 2008 stock option plan: 33,250 shares; 2009 stock option plan: 40,400 shares; 2010 stock option plan: 88,800 shares; 2011 stock option plan: 269,700 shares. Voting and dividend rights attached to these shares are suspended as long as they are held by the Company. Finally it should be mentioned that, under the tender offer by Solvay SA for the shares of Rhodia, liquidity agreements were concluded with employees receiving free shares or options on Rhodia shares to enable these beneficiaries to retain their rights and to sell their Rhodia shares during a specified period after the close of the tender offer. The free shares exposure is fully covered. Treasury share investment program Following the sale of its Pharmaceuticals activities, Solvay launched a treasury share investment program. Investments in Solvay treasury shares over the period March to July 2010, authorized as per resolution of the Extraordinary Shareholders’ Meeting of May 12, 2009, were as followed: Date Period Shares July 26, 2010 from 19/07/2010 to 23/07/2010 880,766 EN FR NL July 19, 2010 from 12/07/2010 to 16/07/2010 830,410 EN FR NL July 13, 2010 from 05/07/2010 to 09/07/2010 811,506 EN FR NL July 5, 2010 from 28/06/2010 to 02/07/2010 721,768 EN FR NL June 14, 2010 from 07/06/2010 to 11/06/2010 641,609 EN FR NL May 31, 2010 from 24/05/2010 to 28/05/2010 602,544 EN FR NL May 25, 2010 from 17/05/2010 to 21/05/2010 489,863 EN FR NL May 17, 2010 from 10/05/2010 to 14/05/2010 207,203 EN FR NL May 10, 2010 from 03/05/2010 to 07/05/2010 143,203 EN FR NL March 1, 2010 from 22/02/2010 to 26/02/2010 54,830 EN FR NL Given the success of the tender offer for Rhodia, the 880,766 shares held by Solvay SA, as temporary partial redeployment of the cash from the sale of the Pharmaceuticals activities, were transferred to the Solvay Stock Option Management SPRL in order to cover the stock options program, see Third Quarter Results 2011, page 17 (October 27). Active analyst coverage Belgian market authority Consensus estimates Dividends Key figures per share Listing & indexes Major shareholders Stock options & treasury shares Stock price FOLLOW US Contact us Privacy & Application Statement Solvay Disclaimer Terms and Conditions and Legal Notice Sitemap E-Business © Solvay 2017 By continuing your online browsing on our website, you accept the use of such cookies.Click here for more information.